Caderso

What Caderso does

Caderso is a privately held pharmaceutical-sector consultancy headquartered in Guadalajara, Jalisco, Mexico, operating with a team of 11–50 employees whose leaders market more than 50 years of combined industry experience. The firm organizes its offering into four service lines: Regulatory Affairs (dossier creation, product registrations and regulatory defense before COFEPRIS, FDA, EMA, ANMAT and INVIMA), Normative Compliance (quality management system implementation, internal and supplier audits, remediation plans and mock inspections against ISO 9001, ISO 13485, 21 CFR Part 820 and NOM-059/241/249 SSA1), Strategic Management (corporate strategy, manufacturing plant design, R&D strategy, QMS design, and turn-key project management), and Training+Development (professional education across the same subject areas). Its primary client base is the pharmaceutical industry, spanning manufacturing sites for medicines, APIs and excipients, medical devices, compounding centers, distribution centers, R&D laboratories, clinical trial centers and pharmacovigilance functions.

The underlying "technology" is human expertise rather than software: Caderso's competitive position rests on a multidisciplinary team of former institutional regulators with working knowledge of Mexican (COFEPRIS, NOM) and international (FDA, EMA, ANMAT, INVIMA, Health Canada, ANVISA) regulatory frameworks. There are no disclosed AI capabilities, software products, APIs, mobile apps, or proprietary data assets; service delivery is project-based professional consulting.

The business model is professional services: revenue is generated through direct, sales-led consulting engagements with enterprise pharmaceutical clients, priced by project scope rather than disclosed rate cards or subscription tiers. Go-to-market is direct sales with close client advisory and follow-up, supported by a bilingual (Spanish/English) website, a blog, and organic social presence on Facebook, Instagram and Twitter. The firm claims to have worked with the largest pharmaceutical companies in Mexico and has been recognized as a Top 10 health-consulting provider in Latin America by Healthcare Business Review.

Name

Caderso

Legal name

Caderso

Website

https://caderso.mx

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Caderso is a Guadalajara-based, privately held consultancy that provides regulatory affairs, normative compliance, strategic management, and training services to pharmaceutical manufacturers, distributors, and R&D organizations across Mexico and Latin America.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)

akta.pro secondary industries

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Product & Consumer Compliance (Labeling, Claims, Safety) (EDABADAH)

Keywords

• Pharmaceutical consulting services
• Regulatory affairs advisory
• Quality management systems
• GMP compliance consulting
• Pharmaceutical strategic management

Headquarters

HQ city

Guadalajara

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Consulting Services: Professional consulting services for regulatory affairs, normative compliance, and strategic management in the pharmaceutical sector

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Caderso is a corporate group of experts providing consulting services for the pharmaceutical sector. Its core offerings cover regulatory affairs (strategy, dossiers, registrations, audit defense before COFEPRIS, FDA, EMA, ANMAT, INVIMA), normative compliance (QMS implementation, audits, remediation, mock inspections), strategic management (manufacturing plant design, R&D strategy, QMS design, strategic marketing, turn-key project management), and training/development for pharmaceutical industry professionals.

Product overview

Caderso is a pharmaceutical consulting firm offering an integrated portfolio of four interconnected service lines: Regulatory Affairs (handling regulatory strategy, dossier management, and product registrations across multiple regulatory bodies), Normative Compliance (implementing and maintaining quality management systems through audits and remediation), Strategic Management (corporate strategy consulting including plant design, R&D implementation, and project management), and Training+Development (professional education services). The services are designed to work together to provide comprehensive support for pharmaceutical companies navigating regulatory compliance and strategic growth.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Parexel International: Parexel is one of the largest global CROs offering regulatory, clinical, and post-market services to pharma and biotech. Its regulatory services portfolio overlaps meaningfully with Caderso's, but at much larger scale and broader geographic footprint.
• Inotiv: Inotiv is a contract research organization providing research models, safety assessment, and regulatory/quality consulting services to pharma and medical device manufacturers. Its regulatory and quality consulting practice overlaps with Caderso's normative compliance and strategic management offerings.
• ICON plc: ICON is a top global CRO providing clinical, regulatory and consulting services to pharma and medical device companies. Its regulatory consulting arm competes with Caderso for multinational pharma clients seeking multi-jurisdiction support.
• IQVIA: IQVIA is the world's largest CRO and life sciences consulting firm, with extensive regulatory affairs, quality, and compliance capabilities across global markets. It competes with Caderso at the high end of the LATAM regulatory market as a broad incumbent.
• Charles River Laboratories: Charles River is a global CRO/CDMO offering regulatory consulting, preclinical, manufacturing and quality services. Its regulatory and quality consulting practice competes with Caderso for pharma manufacturer clients, though at significantly larger scale.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with regulatory, clinical pharmacology, and post-approval services. Its regulatory services offering competes with Caderso, though with broader global delivery infrastructure.

Direct peers

• ProPharma Group: ProPharma Group is a regulatory, compliance and consulting firm serving pharma, biotech and medical device companies with services spanning regulatory affairs, quality compliance, and pharmacovigilance. It is a direct comparable to Caderso in service mix, regulatory focus and target client profile.
• PharmaLex (Cencora): PharmaLex, now part of Cencora, is one of the largest independent regulatory affairs and pharmacovigilance service providers globally, offering strategy, submissions management, and compliance support. It is directly comparable to Caderso's regulatory affairs and quality compliance offerings.
• NSF International: NSF International provides pharma and medical device compliance services including regulatory consulting, QMS audits, training and certification across global frameworks. It directly overlaps with Caderso's normative compliance, regulatory affairs and training services.
• Arriello: Arriello is a regulatory and compliance services firm focused on pharma and life sciences, providing regulatory strategy, submissions, QMS and pharmacovigilance support. It is a direct comparable in scale and service mix to Caderso, especially for multi-jurisdiction LATAM/EU work.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Caderso-100076244468072
• LinkedInlinkedin.com/company/caderso-mx

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caderso